[1]RONGSHOU Z,SIWEI Z,HONGMEI Z,et al.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2(1):1-9.
[2]SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023[J].CA Cancer J Clin,2023,73(1):17-48.
[3]CHANGFA X,XUESI D,HE L,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chinese Medical Journal,2022,5:584-590.
[4]NASIM F,SABATH BF,EAPEN GA.Lung cancer [J].The Medical Clinics of North America,2019,103(3):463-473.
[5]TRAVIS DW,BRAMBILLA E,BURKE PA,et al.Introduction to The 2015 World Health Organization Classification of tumors of the lung,pleura,thymus,and heart[J].Journal of Thoracic Oncology,2015,10(9):1240-1242.
[6]王锐,马彩玲,胡久丽,等.肺腺癌CT表现与病理分级的相关性研究[J].影像科学与光化学,2022,40(2):306-310.
WANG R,MA CL,HU JL,et al.Correlation between CT findings and pathologic grading of lung adenocarcinoma[J].Imaging Science and Photochemistry,2022,40(2):306-310.
[7]YUANQING L,YUE C,XINYI Z,et al.A combination of radiomic features,imaging characteristics,and serum tumor biomarkers to predict the possibility of the high-grade subtypes of lung adenocarcinoma[J].Academic Radiology,2022,29(12):1792-1801.
[8]SARA B,ZINEB B,SANAA G,et al.Correlation of epidermal growth factor receptor mutation with major histologic subtype of lung adenocarcinoma according to IASLC/ATS/ERS classification[J].Cancer Control,2022,29(1):10732748221084930.
[9]YANG Xin,LIN Dongmei.Changes of 2015 WHO histological classification of lung cancer and the clinical significance[J].Chinese Journal of Lung Cancer,2016,19(6):332-336.
[10]CHIHIRO Y,HIROYASU Y,EMI I,et al.High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma[J].General Thoracic and Cardiovascular Surgery,2022,70(5):455-462.
[11]ATSUSHI K,YASUHIRO T,TAKAHIRO K,et al.Utility of newly proposed grading system from international association for the study of lung cancer for invasive lung adenocarcinoma[J].JTO Clinical and Research Reports,2021,2(2):100126.
[12]孙婷婷,伍建林.肺腺癌气腔播散的研究现状与影像学诊断[J].放射学实践,2022,37(02):260-263.
SUN TT,WU JL.Research status and imaging diagnosis of pulmonary adenocarcinoma aerocele dissemination [J].Radiology Practice,2022,37(02):260-263.
[13]LLYAS YAMBAYER,TRAIVIS B SULLIVAN,KIMBERLY RIEGER-CHRIST,et al.Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma:Implications for adjuvant therapy[J].Lung Cancer,2022,171:82-89.
[14]RYO F,YUJI M,JUMPEI K,et al.Clinicopathologic and genotypic features of lung adenocarcinoma characterized by the international association for the study of lung cancer grading system[J].Journal of Thoracic Oncology,2022,17(5):700-707.
[15]GUTIERREZ-SAINZ L,LOPEZ-MUNOZ S,CRUZ-CASTELLANOS P,et al.Retrospective analysis of the prognostic implications of tumor spread through air spaces in lung adenocarcinoma patients treated with surgery[J].ESMO Open,2022,7(5):100568.
[16] KUNIO A,YOSHITERU K,KEIKO H,et al.Excellent prognosis of lepidic-predominant lung adenocarcinoma:low incidence of lymphatic vessel invasion as a key factor[J].Anticancer Research,2014,34(6):3153-3156.
[17]HOU LK,ZHANG LP,HUANG Y,et al.Application of the WHO Classification of Thoracic Tumors (2021) grading system in invasive pulmonary adenocarcinoma and its correlation with the targeted genes' variations[J]. Chinese Journal of Pathology,2023,52(2):129-135.
[18]DENG C,ZHENG Q,ZHANG Y,et al.Validation of the novel international association for the study of lung cancer grading system for invasive pulmonary adenocarcinoma and association with common driver mutations[J].J Thorac Oncol,2021,16(10):1684-1693.